Wang W - Search Results

1

Genomic Space of MGMT in Human Glioma Revisited: Novel Motifs, Regulatory RNAs, NRF1, 2, and CTCF Involvement in Gene Expression.

Ibrahim Al-Obaide MA, Arutla V, Bacolod MD, Wang W, Zhang R, Srivenugopal KS. Ibrahim Al-Obaide MA, et al. Among authors: wang w. Int J Mol Sci. 2021 Mar 2;22(5):2492. doi: 10.3390/ijms22052492. Int J Mol Sci. 2021. PMID: 33801310 Free PMC article.

2

Experimental Therapy of Advanced Breast Cancer: Targeting NFAT1-MDM2-p53 Pathway.

Qin JJ, Wang W, Zhang R. Qin JJ, et al. Among authors: wang w. Prog Mol Biol Transl Sci. 2017;151:195-216. doi: 10.1016/bs.pmbts.2017.07.005. Epub 2017 Aug 31. Prog Mol Biol Transl Sci. 2017. PMID: 29096894 Free PMC article. Review.

3

Targeted Brain Tumor Therapy by Inhibiting the MDM2 Oncogene: In Vitro and In Vivo Antitumor Activity and Mechanism of Action.

Punganuru SR, Artula V, Zhao W, Rajaei M, Deokar H, Zhang R, Buolamwini JK, Srivenugopal KS, Wang W. Punganuru SR, et al. Among authors: wang w. Cells. 2020 Jul 1;9(7):1592. doi: 10.3390/cells9071592. Cells. 2020. PMID: 32630235 Free PMC article.

4

Polycomb Group (PcG) Proteins and Human Cancers: Multifaceted Functions and Therapeutic Implications.

Wang W, Qin JJ, Voruganti S, Nag S, Zhou J, Zhang R. Wang W, et al. Med Res Rev. 2015 Nov;35(6):1220-67. doi: 10.1002/med.21358. Epub 2015 Jul 30. Med Res Rev. 2015. PMID: 26227500 Free PMC article. Review.

5

Pharmacokinetics and Pharmacodynamics in Breast Cancer Animal Models.

Wang W, Nag S, Zhang R. Wang W, et al. Methods Mol Biol. 2016;1406:271-87. doi: 10.1007/978-1-4939-3444-7_23. Methods Mol Biol. 2016. PMID: 26820963 Free PMC article.

6

Novel natural product therapeutics targeting both inflammation and cancer.

Qin J, Wang W, Zhang R. Qin J, et al. Among authors: wang w. Chin J Nat Med. 2017 Jun;15(6):401-416. doi: 10.1016/S1875-5364(17)30062-6. Chin J Nat Med. 2017. PMID: 28629530 Free PMC article. Review.

7

Inhibiting NFAT1 for breast cancer therapy: New insights into the mechanism of action of MDM2 inhibitor JapA.

Qin JJ, Wang W, Voruganti S, Wang H, Zhang WD, Zhang R. Qin JJ, et al. Among authors: wang h, wang w. Oncotarget. 2015 Oct 20;6(32):33106-19. doi: 10.18632/oncotarget.5851. Oncotarget. 2015. PMID: 26461225 Free PMC article.

8

Two Birds with One Stone: NFAT1-MDM2 Dual Inhibitors for Cancer Therapy.

Wang W, Zafar A, Rajaei M, Zhang R. Wang W, et al. Cells. 2020 May 9;9(5):1176. doi: 10.3390/cells9051176. Cells. 2020. PMID: 32397368 Free PMC article. Review.

9

Targeting the p53-MDM2 pathway for neuroblastoma therapy: Rays of hope.

Zafar A, Wang W, Liu G, Xian W, McKeon F, Zhou J, Zhang R. Zafar A, et al. Among authors: wang w. Cancer Lett. 2021 Jan 1;496:16-29. doi: 10.1016/j.canlet.2020.09.023. Epub 2020 Sep 29. Cancer Lett. 2021. PMID: 33007410 Free PMC article. Review.

10

Identification of a new class of natural product MDM2 inhibitor: In vitro and in vivo anti-breast cancer activities and target validation.

Qin JJ, Wang W, Voruganti S, Wang H, Zhang WD, Zhang R. Qin JJ, et al. Among authors: wang h, wang w. Oncotarget. 2015 Feb 20;6(5):2623-40. doi: 10.18632/oncotarget.3098. Oncotarget. 2015. PMID: 25739118 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89,149 results

Search Page

Filters